Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 6NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Mucositis 2Squamous Cell Carcinoma of Head and Neck 1Radiation Injuries 1Pain 1Neoplasms 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Hodgkin Disease 1Head and Neck Neoplasms 1

Interventions

fludarabine phosphate 2fludarabine 2Whole-Body Irradiation 2Tacrolimus 2Surveys and Questionnaires 2Proton Therapy 2Peripheral Blood Stem Cell Transplantation 2Patient Reported Outcome Measures 2Mycophenolic Acid 2Music Therapy 2Mesna 2Melphalan 2Interviews as Topic 2Gene Expression Profiling 2Cyclophosphamide 2Busulfan 2tremelimumab 1motesanib diphosphate 1luprolide acetate gel depot 1liposomal amphotericin B 1durvalumab 1copanlisib 1chlorhexidine gluconate 1batifiban 1Whole Genome Sequencing 1Watchful Waiting 1Thrombopoietin 1Taxes 1Spermine Synthase 1Radiotherapy, Intensity-Modulated 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Neoplasms × Fibroblast Growth Factor 7 × Clear all
NCT00728585 2018-08-07

Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell Transplant

Children's Oncology Group

Phase 2 Withdrawn
Other

Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡